Avidity Biosciences (NASDAQ:RNA) reported quarterly losses of $(0.70) per share. This is a 43.09 percent increase over losses of $(1.23) per share from the same period last year. The company reported $2.61 million in sales this quarter. This is a 69.18 percent increase over sales of $1.54 million the same period last year.
Avidity Biosciences Q2 EPS $(0.70) Up From $(1.23) YoY, Sales $2.61M Up From $1.54M YoY
Avidity Biosciences (NASDAQ:RNA) reported quarterly losses of $(0.70) per share. This is a 43.09 percent increase over losses of $(1.23) per share from the same period last year. The company reported $2.61 million in
